Study of the Prognostic Impact of CD44 on Renal Cell Carcinoma
NCT06773377 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 77
Last updated 2025-01-14
Summary
1. Study the expression of CD44 in various histopathological types of RCC.
2. Study the association between CD44 expression and other clinicopathological parameters
3. study the impact of CD44 expressions in tumor and patients' survival
Conditions
- Renal Cell Cancer
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-11-01
- Primary Completion
- 2026-11-01
- Completion
- 2026-12-01
More Related Trials
-
A Multimodal Predictive Recurrence Score for Patients With Clear Cell Renal Cell Carcinoma
NCT06656039 ·Status: COMPLETED
-
A CT-BASED Deep Learning Model for Predicting WHO/ISUP Pathological Grades of Clear Cell Renal Cell Carcinoma (ccRCC) :A Multicenter Cohort Study
NCT06559046 ·Status: COMPLETED
-
Methylation Status of CD44 Promoter Region in Primary Lung Cancer
NCT00173680 ·Status: UNKNOWN
-
A Study Based on CT Radiomics for Distinguishing Benign From Malignant Renal Tumors and Assessing Their Aggressiveness.
NCT07060248 ·Status: ACTIVE_NOT_RECRUITING
-
Prognostic Significance of the Lung Immune Prognostic Index (LIPI) in Postoperative Clear Cell Renal Cell Carcinoma: a Multicenter Retrospective Cohort Study
NCT06775574 ·Status: COMPLETED
-
A Study of the Gene Mutation Status in Cerebrospinal Fluid, Blood and Tumor Tissue of Non-small Cell Lung Cancer Patients With Brain Metastases
NCT03257735 ·Status: UNKNOWN
-
Novel Biomarkers of Hypoxia and Metabolism in Clear Cell Renal Cell Carcinoma
NCT05214885 ·Status: RECRUITING
-
Application of Radiomics-based AI Models in Predicting Clinical Outcome of Patients With Renal Cell Carcinoma After Surgical Treatment
NCT07118813 ·Status: RECRUITING
-
PD-L1 Expression on CTCs in HNSCC Patients Underwent Curative CCRT
NCT05008796 ·Status: UNKNOWN
-
CXCR4 PET/CT for Predicting Outcome in Limited-Stage Small Cell Lung Cancer
NCT07316309 ·Status: COMPLETED
-
Explore Intra-tumor Heterogeneity and Prognostic Value of Postoperative Blood ctDNA of ⅡA - ⅢA Stage Non-squamous NSCLC Based on the Capture-based Sequencing and UMI Technology of Burning Rock
NCT03337711 ·Status: UNKNOWN
-
Gene Mutations in Non-Small Cell Lung Cancer Cells
NCT00977509 ·Status: UNKNOWN
-
Optimising Renal Tumour Management Through Artificial Intelligence Modules
NCT06714916 ·Status: RECRUITING
-
Correlation Study of Lipid Metabolites as Markers of Hepatocellular Carcinoma
NCT06623474 ·Status: RECRUITING
-
Adrenal Project: Clinical and Epidemiological Characterization of Adrenocortical Carcinoma in a Brazilian Cohort
NCT06279442 ·Status: RECRUITING
-
The Role of Stromal Cell-Derived Factor-1 (SDF-1)/CXC Chemokine Receptor 4 (CXCR4) in Metastasis of Laryngeal and Hypopharyngeal Squamous Cell Carcinoma
NCT00174096 ·Status: UNKNOWN
-
Identify Prognostic Biomarkers of Lung Cancer
NCT05010330 ·Status: UNKNOWN
-
Study of Biomarker From Blood and Tissue of Head and Neck Carcinoma
NCT01171235 ·Status: UNKNOWN
-
Deep Learning for Automated Discrimination Between Stage T1-T2 and T3 Renal Cell Carcinoma on Contrast-Enhanced CT
NCT07166445 ·Status: RECRUITING
-
T Regulatory Cells in Renal Cell Carcinoma (PILOT STUDY)
NCT00717743 ·Status: COMPLETED
-
Prognostic Value of CD4/CD8 Ratio in Patients with Nasopharyngeal Carcinoma
NCT06762470 ·Status: ACTIVE_NOT_RECRUITING
-
Tertiary Lymphoid Structures in Nasopharyngeal Carcinoma
NCT06770699 ·Status: ACTIVE_NOT_RECRUITING
-
An Exploratory Study of ctDNA-MRD in Predicting the Efficacy of Esophageal Squamous Cell Carcinoma
NCT05759325 ·Status: NOT_YET_RECRUITING
-
The Chinese Pulmonary Lymphoepithelioma-like Carcinoma Collaboration Study
NCT06801977 ·Status: RECRUITING
-
Chinese Research Group of Gallbladder Cancer
NCT04140552 ·Status: RECRUITING